ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,333.80
0.24%
S&P ASX All Technology
3,896.90
0.86%
Brent Oil
73.185
0.11%
US Dollar vs AUD
1.58009
0.15%
Bitcoin
105,995.80
-0.15%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Vivoryon Therapeut (VVY) Share Price

Vivoryon Therapeut

Vivoryon Therapeut (VVY)

EU
1.96
0.02
(1.03%)
Closed 18 December 3:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.96
Bid
1.93
Offer
2.01
Volume
90,602
1.922 Day's Range 1.988
0.41 52 Week Range 9.93
Market Cap
-
Previous Close
1.94
Open
1.96
Last Trade
1
@
1.96
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
237,342
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
-3.62M
Net Profit
-28.34M

About Vivoryon Therapeut

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vivoryon.com
Headquarters
Halle, Deu
Founded
-
Vivoryon Therapeut is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker VVY. The last closing price for Vivoryon Therapeut was 1.94 €. Over the last year, Vivoryon Therapeut shares have traded in a share price range of 0.41 € to 9.93 €.

Vivoryon Therapeut currently has 0 shares in issue.

Ask ADVFN Intelligence (AI)

VVY Latest News

More News

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function Vivoryon Therapeutics N.V. Presents Topline Phase...

09 December 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024 Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress...

04 December 2024
UK Regulatory

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of...

26 October 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 Halle (Saale) / Munich, Germany, October 11, 2024 – Vivoryon...

12 October 2024
UK Regulatory

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event Halle (Saale) / Munich, Germany, October 1, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY;...

01 October 2024
UK Regulatory

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease Vivoryon Therapeutics N.V...

12 September 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and...

06 September 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024 Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial...

05 September 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in...

18 July 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Halle (Saale) / Munich, Germany, July 9, 2024 - Vivoryon Therapeutics N.V. (Euronext...

09 July 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.48-19.67213114752.442.441.884207131.96185034DE
4-0.095-4.622871046232.0552.71.673096902.20101916DE
12-0.15-7.109004739342.112.9951.672373422.32526285DE
26-0.21-9.677419354842.172.9951.3242940132.20816777DE
52-5.94-75.18987341777.99.930.415591902.02462688DE
156-15.16-88.551401869217.1220.6350.412296243.79746643DE
260-3.19-61.94174757285.1523.250.411768135.12671156DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
110.65M
MLWEYWeya
0.02 €
(53.85%)
208.3k
ALPCVCerinnov Group
0.918 €
(37.01%)
169.44k
MLLOILocasystem International
14.90 €
(16.41%)
4
UNBLUnibel
965.00 €
(16.27%)
154
MLFTIFrance Tourisme Immobilier
0.015 €
(-50.00%)
6.7k
ALEXPOne Experience
0.31 €
(-18.42%)
250
ALBDMBD Multi-Media
0.76 €
(-18.28%)
440
ALMARMare Nostrum
0.36 €
(-15.89%)
2.1k
CNVCnova NV
0.26 €
(-15.03%)
10.19k
ATOAtos SE
0.0016 €
(-11.11%)
4.45B
ALCYBCybergun
0.0002 €
(100.00%)
110.65M
BCPBanco Comercial Portugues SA
0.4451 €
(-2.45%)
59.27M
BIOSBiosenic
0.007 €
(-2.78%)
32.95M
VIVVivendi SE
2.507 €
(-3.87%)
29.34M

Discussion

View Full Feed
RobotDroid RobotDroid 1 minute ago
Again, not impossible. The track record of this POS is one good trial followed by multiple failures and mute inept nonmanagement. So far, only the lp clowns have made bank on the share grift.
NWBO
HGilS HGilS 1 minute ago
Nasrat knows Vyvanse will be approved 2 months ago already. He wants to ship it as early as possible and even more than you and me.
ELTP
Investor082 Investor082 3 minutes ago
LOL, there will be no settlement any time soon. This will drag on for couple of more years.
NWBO
delerious1 delerious1 3 minutes ago
The last few weeks of trading have been great...pretty weak excuse for not making easy money and I ain't buying what some're selling....the fact is the stock is doing quite well, frustrating at times but going in the right direction....and we all (or at least most) know that this is going to be big.
NBRI
miketherage miketherage 3 minutes ago
Yeah just been around ihub long enough.  I'm just sick of the posters here no DD ... just hate.
BBAI
uber darthium uber darthium 4 minutes ago
Yeah, remember the pressure differential at the mouth of the pipe when the drain valve were to be opened, and how this would literally rip and tear live shrimp into shreds
SHMP
arizona1 arizona1 4 minutes ago
I listened to the whole thing while I was making dinner. It was really good.
ORCA ORCA 4 minutes ago
IT IS EXTREMELY HARD TO BELIEVE FOR SO MANY YEARS NOW WE CAN NOT STAY ABOVE .01.AND TRADE IN THE .03 TO .05 AREA.ONE HAS TO WONDER WHERE THE F THE SHARES ARE COMING FROM.
RJDG
WALL STREET KID WALL STREET KID 5 minutes ago
Right on right on
OGI
RobotDroid RobotDroid 5 minutes ago
2 billion shares just around the corner to line the fat pockets of linda worthless and fill SH stockings with poop caked coal. Merry Christmas from biotechs Satan.
NWBO
FlyingDutchman FlyingDutchman 5 minutes ago
Get out of here with your 300 OSand you ask me why?
saxxie2 saxxie2 5 minutes ago
https://x.com/cleves_trades/status/1869121190465548555?s=61&t=2YkAu6F6n9ueNrIHgJBtVg
NWBO
IH Admin [Shelly] IH Admin [Shelly] 5 minutes ago
Interestingly, you're trying to make having another long time account into some sort of political persecution?
3331 3331 5 minutes ago
BIEL: HOT new pain relief product - Actipatch!
https://www.facebook.com/share/p/182kSvscPg/
Greenpower1 Greenpower1 5 minutes ago
Breaking news from Moller. We shareholders rejoice. Call them now and get the latest.
Investor082 Investor082 5 minutes ago
Highly unlikely.
NWBO
Viewmont Viewmont 5 minutes ago
https://x.com/MoMoney55648965/status/1869069366568112461
ADHC
dinogreeves dinogreeves 6 minutes ago
Fantastic move, still have my shares. Waiting for dollars. Only 34,000 shares. I don't need this, so waiting is the best approach.
TGRP
ron_66271 ron_66271 6 minutes ago
More LIBOR Documents. JPM Named.

Why today?


https://www.docketbird.com/court-cases/In-re-Libor-Based-Financial-Instruments-Antitrust-Litigation/nysd-1:2011-md-02262



Ron
JPM
CanItBThisEZ2Make CanItBThisEZ2Make 6 minutes ago
$MAXN
Buy: 251,307
Neutral: 99,492
Sell: 296,336
Volume: 647,135
MAXN
jb92106 jb92106 6 minutes ago
From Dmdmd1 Boadpost part 2;

2) https://www.boardpost.net/forum/index.php?topic=16689.msg300668#msg300668

Read the whole post

March 06, 2021, 06:33:43 AM
Quote from: Dmdmd1 on February 13, 2021, 10:26:19 AM


Both the subpoena
COOP
manibiotech manibiotech 6 minutes ago
And there is only one vaccine in the world of course . 
And they couldn't give good faith loan of 20M to NWBo whose success and continued operations will be pre requisite to use that building
NWBO
splintered sunlight splintered sunlight 6 minutes ago
Wasn't always this way............

UGH
TTNN
ORCA ORCA 6 minutes ago
THE JELLY BEANS GOT SCARED,WITH MY BIG BIDS.LOL.THEY WERE CUTTING IN FRONT OF MY BIDS.SO I DO NOT GET FILLS.LMAO.
VDRM
uber darthium uber darthium 7 minutes ago
Yes, I believe they see both of themselves in the same mirror if tried
GDSI

Your Recent History

EU
VVY
Vivoryon Therapeut
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved